Polysomnography systems market seen reaching $1.79 billion by 2030

The Business Research Company says the global polysomnography systems market is on track to grow from $1.51 billion in 2026 to $1.79 billion by 2030, driven by rising sleep disorder diagnoses, home testing, and remote monitoring. North America led the market in 2025, while Asia-Pacific is projected to be the fastest-growing region.

Why it matters: - Polysomnography systems are central to diagnosing sleep apnea, insomnia, narcolepsy and other sleep-related conditions. - Rising demand for sleep diagnostics is pushing hospitals, sleep clinics and home-testing providers to invest in more advanced monitoring tools. - The market’s growth signals broader adoption of digital and remote care for neurological and respiratory conditions.

What happened: - The Business Research Company released a polysomnography systems market report covering 2026 to 2035. - The report says the market will rise from $1.44 billion in 2025 to $1.51 billion in 2026. - The report projects the market will reach $1.79 billion by 2030, implying a 4.4% CAGR over the forecast period. - The company published the report from London on September 10, 2026. - Download a free sample of the report. - View the full market report.

The details: - Polysomnography systems track brain waves, eye movements, muscle activity, heart rhythms, respiratory effort, airflow and blood oxygen saturation during sleep. - The systems help healthcare providers diagnose and evaluate sleep apnea, insomnia, narcolepsy and other sleep disorders. - Historical growth from 2025 to 2026 was linked to limited public awareness, dependence on hospital-based sleep labs, rising sleep apnea diagnoses, broader adoption in advanced healthcare systems and manual sleep study analysis. - The report says future growth will be driven by more sleep-related breathing disorders, wider use of home sleep testing, telehealth, remote patient monitoring, wearable sleep diagnostics and stronger focus on neurological and respiratory diagnostics. - Emerging trends include home-based and portable diagnostic devices, wireless and cloud-connected monitoring, more diagnosis of neurological sleep conditions, more specialized sleep clinics and broader multi-channel physiological monitoring. - In 2025, North America held the largest global market share. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Sleep disorder diagnoses are becoming a bigger commercial driver because more patients need objective testing, not just symptom screening. - The emphasis on home and wireless monitoring suggests the market is shifting away from lab-only workflows. - A January 2026 National Library of Medicine report found diagnosed sleep disorders among U.S. adults ages 40 to 59 rose from 334.0 per 100,000 in 2023 to 362.8 per 100,000 in 2024. - That trend supports continued demand for diagnostic systems that can handle higher volumes and more varied care settings.

What's next: - The market is expected to keep expanding as sleep testing moves into homes, clinics and connected care programs. - The report says 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated trend analysis. - That suggests vendors will keep competing on portability, connectivity and data integration rather than lab-only hardware.